National Granted Programs and Public Funds for Biopharmaceutical Startups in Japan
ABSTRACT In Japan, biopharmaceutical startups have not been sufficiently nurtured, leading to weak international competitiveness in new drug development. This is partly due to low levels of entrepreneurship in the private sector and limited investment in startups. Therefore, it is crucial for the Ja...
Saved in:
| Main Author: | Ryo Okuyama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Pharmacology Research & Perspectives |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/prp2.70106 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
InvestTrack: Design and development of online system for startups investment funding
by: Fritz M. Abrea, et al.
Published: (2025-06-01) -
Innovative voucher as a prospect tool for grant funding
by: V. A. Barinova, et al.
Published: (2015-02-01) -
IMPACT AND INVESTMENT PERFORMANCE AMONG ROMANIAN STARTUPS
by: ION-MATEI DUMITRESCU, et al.
Published: (2025-06-01) -
Specialized Venture Capital Funds as a Tool for Supporting Investment in Advanced Technologies
by: О. А. Eremchenko
Published: (2021-11-01) -
Strategic aspects of staffing industrial biopharmaceutical companies
by: A. S. Glazkova, et al.
Published: (2020-01-01)